Radical resection of hilar bile duct carcinoma and predictors of survival

British Journal of Surgery

Volumn 87, Issue 3, 2000, Pages 306-313

  Todoroki, T ^a   Kawamoto, T ^a   Koike, N ^a   Takahashi, H ^a   Yoshida, S ^a   Kashiwagi, H ^a   Takada, Y ^a   Otsuka, M ^a   Fukao, K ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; DISEASE SEVERITY; FEMALE; HEPATIC DUCT; HISTOPATHOLOGY; HUMAN; JAUNDICE; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; SURGICAL MORTALITY; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; FEMALE; HEPATIC DUCT, COMMON; HUMANS; MALE; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0034017274     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.2000.01343.x     Document Type: Article

References (31)

1. 1 Nimura Y, Kamiya J, Nagino M, Kanai M, Uesaka K, Kondo S et al. Aggressive surgical treatment of hilar cholangiocarcinoma. Journal of Hepato-Biliary-Pancreatic Surgery 1998; 5: 52-61.
2. 2 Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis: an unusual tumor with distinctive clinical and pathological features. Am J Med 1965; 38: 241-56.
3. 3 Furue H, Hara Y, Imai Y, Kimura T, Koyama Y, Kurihara M et al. Criteria for the evaluation of direct effects of solid cancer chemotherapy. Journal of the Japanese Society of Cancer Therapy 1993; 28: 101-18.
4. 4 Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP et al., eds. AJCC Cancer Staging Manual. 5th ed. Philadelphia, Pennsylvania: Lippincott-Raven, 1997.
5. 5 Todoroki T, Gunderson LL, Nagorney D. Biliary tract IORT; bile duct and gallbladder. In: Gunderson LL, Willet CG, Harrison LB, Calvo FA, eds. Intraoperative Irradiation; Techniques and Results. Totowa, New Jersey: Humana Press, 1999: 223-47.
6. 6 Choen J. A coefficient of agreement for nominal scales. Education and Psychological Measurement 1960; 20: 37-46.
7. 7 Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 1975; 140: 170-8.
8. 8 Pitt HA, Cameron JL, Postier RG, Gadacz TR. Factors affecting mortality in biliary tract surgery. Am J Surg 1981; 141: 66-72.
9. 9 Blamey SL, Fearon KC, Gilmour WH, Osborne DH, Carter DC. Prediction of risk in biliary surgery. Br J Surg 1983; 70: 535-8.
10. 10 Su CH, P'eng FK, Lui WY. Factors affecting morbidity and mortality in biliary tract surgery. World J Surg 1992; 16: 536-40.
11. 11 Su CH, Tsay SH, Wu CC, Shyr YM, King KL, Lee CH et al. Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg 1996; 223: 384-94.
12. 12 Todoroki T, Okamura T, Fukao K, Nishimura A, Otsu H, Sato H et al. Gross appearance of carcinoma of the main hepatic duct and its prognosis. Surg Gynecol Obstet 1980; 150: 33-40.
13. 13 Tompkins RK, Thomas D, Wile A, Longmire WP Jr. Prognostic factors in bile duct carcinoma: analysis of 96 cases. Ann Surg 1981; 194:447-57.
14. 14 Nagorney DM, Donohue JH, Farnell MB, Schleck CD, Ilstrup DM. Outcomes after curative resections of cholangiocarcinoma. Arch Surg 1993; 128: 871-7; discussion 877-9.
15. 15 Gertsch P, Thomas P, Baer H, Lerut J, Zimmermann A, Blumgart LH. Multiple tumors of the biliary tract. Am J Surg 1990; 159: 386-8.
16. 16 Klempnauer J, Ridder GJ, von Wasielewski R, Werner M, Weimann A, Pichlmayr R. Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol 1997; 15: 947-54.
17. 17 Klempnauer J, Ridder GJ, Werner M, Weimann A, Pichlmayr R. What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer 1997; 79: 26-32.
18. 18 Burke EC, Jarnagin WR, Hochwald SN, Pisters PWT, Fong Y, Blumgart LH. Hilar cholangiocarcinoma patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg 1998; 228: 385-94.
19. 19 Ishiyama S, Fuse A, Kuzu H, Igarashi Y, Urayama M, Suto K et al. Results of surgical treatments and prognostic factors for hepatic hilar bile duct cancer. Journal of Hepato-Biliary-Pancreatic Surgery 1998; 5: 429-36.
20. 20 Kusano T, Tamai O, Miyazato H, Isa T, Shiraishi M, Muto M et al. Surgical treatment for proximal bile duct carcinoma. Int Surg 1998; 83: 119-23.
21. 21 Miyazaki M, Ito H, Nakagawa K, Ambiru S, Shimizu H, Shimizu Y et al. Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection? Surgery 1998; 123: 131-6.
22. 22 Ogura Y, Kawarada Y. Surgical strategies for carcinoma of the hepatic duct confluence. Br J Surg 1998; 85: 20-4.
23. 23 Buskirk SJ, Gunderson LL, Schild SE, Bender CE, Williams HJ Jr, McIlrath DC et al. Analysis of failure after curative irradiation of extrahepatic bile duct carcinoma. Ann Surg 1992; 215: 125-31.
24. 24 Cameron JL, Pitt HA, Zinner MJ, Kaufman SL, Coleman J. Management of proximal cholangiocarcinomas by surgical resection and radiotherapy. Am J Surg 1990; 159: 91-7; discussion 97-8.
25. 25 Gonzalez Gonzalez D, Gerard JP, Maners AW, De la Lande-Guyaux B, Van Dijk-Milatz A, Meerwaldt JH et al. Results of radiation therapy in carcinoma of the proximal bile duct (Klatskin tumor). Semin Liver Dis 1990; 10: 131-41.
26. 26 Iwasaki Y, Todoroki T, Fukao K, Ohara K, Okamura T, Nishimura A. The role of intraoperative radiation therapy in the treatment of bile duct cancer. World J Surg 1988; 12: 91-8.
27. 27 Pitt HA, Gomes AS, Lois JF, Mann LL, Deutsch LS, Longmire WP Jr. Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost? Ann Surg 1985; 201: 545-53.
28. 28 Shiina T, Mikuriya S, Uno T, Toita T, Serizawa S, Itami J et al. Radiotherapy of cholangiocarcinoma: the roles for primary and adjuvant therapies. Cancer Chemother Pharmacol 1992; 31(Suppl): S115-18.
29. 29 Todoroki T, Iwasaki Y, Okamura T, Nagoshi K, Asakura H, Nakano M et al. Intraoperative radiotherapy for advanced carcinoma of the biliary system. Cancer 1980; 46: 2179-84.
30. 30 Verbeek PC, Van Leeuwen DJ, Van Der Heyde MN, Gonzalez Gonzalez D. Does additive radiotherapy after hilar resection improve survival of cholangiocarcinoma? An analysis in sixty-four patients. Ann Chir 1991; 45: 350-4.
31. 31 Pitt HA, Nakeeb A, Abrams RA, Coleman J, Piantadosi S, Yeo CJ et al. Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg 1995; 221: 788-97; discussion 797-8.